N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide
Structure Info
- Chemspace ID
- CSSB21332125749 (In-Stock Building Blocks)
- IUPAC Name
- N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide
- Mol formula
- C16H14N2O2S2
- Mol weight
- 330 Da
- Catalog Number(s)
- BBLS21332125749, EN300-54824430, bbls21332125749
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 3.3
- Heavy atoms count
- 22
- Rotatable bond count
- 4
- Number of rings
- 3
- Carbon bond saturation, Fsp3
- 0.062
- Polar surface area (Å)
- 59
- Hydrogen bond acceptors count
- 3
- Hydrogen bond donors count
- 1
![Chemical structure of N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide (C16H14N2O2S2) - CSSB21332125749](/st/structure/200/6fa2a0e59675ae7a8ea242ee6788873a/C%253DCS%2528%253DO%2529%2528%253DO%2529NC%2528C1%253DNC2%253DC%2528S1%2529C%253DCC%253DC2%2529C1%253DCC%253DCC%253DC1.png "C16H14N2O2S2")
- Zoom the structure
- CSSB21332125749
Items Overall 8 items from 1 supplier
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 50 mg | 515.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 100 mg | 539.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 250 mg | 564.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 500 mg | 589.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 1 g | 614.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 2.5 g | 1,202.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 5 g | 1,779.00 | |
| Enamine Ltd. | 15 days | Ukraine To: | 95 | 10 g | 2,638.00 |
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire
Similarity Analogs
![Chemical structure of N-[1-(1,3-benzothiazol-2-yl)ethyl]ethene-1-sulfonamide - CSSB21332102603](/st/structure/200/087ebd3d53ca62cf112897e160d35524/CC%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DNC2%253DC%2528S1%2529C%253DCC%253DC2.png)
![Chemical structure of N-[(1,3-benzothiazol-2-yl)(phenyl)methyl]prop-2-enamide - CSSB00697456304](/st/structure/200/fd4d722a011e07f19d44cb817aac927c/C%253DCC%2528%253DO%2529NC%2528C1%253DNC2%253DCC%253DCC%253DC2S1%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[(4-methyl-1,3-thiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide - CSSB21332082084](/st/structure/200/e3ce97a5b407d11cc01f608a980a0558/CC1%253DCSC%2528%253DN1%2529C%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DCC%253DCC%253DC1.png)
![Chemical structure of N-[1-(1,3-benzothiazol-2-yl)propan-2-yl]ethene-1-sulfonamide - CSSB21332110214](/st/structure/200/34c201ce6f9efb92d0027b3c579d4829/CC%2528CC1%253DNC2%253DC%2528S1%2529C%253DCC%253DC2%2529NS%2528%253DO%2529%2528%253DO%2529C%253DC.png)
![Chemical structure of N-[(1,3-benzothiazol-2-yl)methyl]ethene-1-sulfonamide - CSSB02138435757](/st/structure/200/356ceccbbf1c3a1f041754b16461d125/C%253DCS%2528%253DO%2529%2528%253DO%2529NCC1%253DNC2%253DCC%253DCC%253DC2S1.png)
![Chemical structure of N-[(1-methyl-1H-1,3-benzodiazol-2-yl)(phenyl)methyl]ethene-1-sulfonamide - CSSB06713687301](/st/structure/200/d858c618234ed396ee0389a6fca807b8/C%253DCS%2528%253DO%2529%2528%253DO%2529NC%2528C1%253DCC%253DCC%253DC1%2529C1%253DNC2%253DC%2528C%253DCC%253DC2%2529N1C.png)
![Chemical structure of N-[(1-methyl-1H-pyrazol-3-yl)(phenyl)methyl]ethene-1-sulfonamide - CSSB21332101802](/st/structure/200/80a93a6dbfcaed31d5450cdf7b4d5b9b/CN1C%253DCC%2528%253DN1%2529C%2528NS%2528%253DO%2529%2528%253DO%2529C%253DC%2529C1%253DCC%253DCC%253DC1.png)
